Status:
COMPLETED
Near-infrared Spectroscopy-based Neurofeedback as Adjunct to Mindfulness-Oriented Recovery Enhancement in Persons With Chronic Pain
Lead Sponsor:
University of Utah
Conditions:
Chronic Pain Syndrome
Opioid Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary aim of this pilot trial is to enhance the efficacy of the Mindfulness-Oriented Recovery Enhancement (MORE) intervention by adding neurofeedback (NF) of the Orbitofrontal Cortex (OFC) as an...
Eligibility Criteria
Inclusion
- ≥18 years of age,
- ability to understand and speak the English language
- current chronic pain-related diagnosis
Exclusion
- mindfulness training experience (e.g., participation in MBSR/MBRP)
- neurofeedback experience
- current cancer diagnosis
- having a psychiatric or medical condition that precludes the ability to provide informed consent or participation in outpatient treatment (e.g., psychosis, mania, acute intoxication)
- suicidal ideation with a plan in the past week, or a suicide attempt in the past 3 months
- unwilling, unable, or unlikely to complete study procedures (e.g., planned major surgery, anticipated move, travel barrier)
- communication or cognitive impairment that limits participation in group treatment or study procedures
Key Trial Info
Start Date :
April 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2025
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT04902339
Start Date
April 3 2021
End Date
April 3 2025
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center on Mindfulness and Integrative Health Intervention Development
Salt Lake City, Utah, United States, 84112